1.58 USD
↗ 0.35 (28.46%)AT CLOSE (11:59 AM EDT)
Actuate Therapeutics, Inc. Common stock
ACTUNASDAQ • USD
1.74
↗ 0.16 (10.13%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
1.74
↗ 0.16 (10.13%)
Market: OPEN
ACTU is currently priced at $1.74. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 25, 2026.
Open?$1.24
High?$1.58
Low?$1.20
Prev. Close?$1.23
Volume?584.0K
Avg. Volume?295.8K
VWAP?$1.45
Rel. Volume?1.97x
Bid / Ask
Bid?$1.23 × 100
Ask?$1.83 × 100
Spread?$0.60
Midpoint?$1.53
Valuation & Ratios
Market Cap?29.5M
Shares Out?24.0M
Float?9.5M
Float %?40.3%
P/E Ratio?N/A
P/B Ratio?29.86
EPS?-$0.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Employees
12
Market Cap
29.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-08-13
Address
1751 RIVER RUN
FORT WORTH, TX 76107
Phone: 847-986-4190
FORT WORTH, TX 76107
Phone: 847-986-4190
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?30
Piotroski F-Score?0/9Weak
Altman Z-Score?-53.21Distress
Confidence?42%Low
Short InterestElevated
Short % of Float?7.29%Elevated
Short Interest?696.0K
Days to Cover?3.6
Free Float9.5M
Avg Daily Volume193.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?1.16Strong
Debt/Equity?0.04Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?29.86HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-2,067.8%WEAK▾
S&P3
ROA?-393.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-19836202
Enterprise Value?$25.1M
Fundamentals ratios updated end of day